DavidBHallMD

PubMed

• 164 citations
  Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis
  Hervé Bachelez, Siew Eng Choon, Slaheddine Marrakchi, A. David Burden, Tsen-Fang Tsai, Akimichi Morita, Hamida Turki, David B. Hall, Michael Shear, Patrick Baum, Steve...> ;The New England Journal of Medicine. 2019 Mar 6
• 104 citations
  Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study.
  Brian G. Feagan, Julián Panés, Marc Ferrante, Arthur Kaser, Geert R. D'Haens, William J. Sandborn, Edouard Louis, Markus F. Neurath, Denis Franchimont, Olivier Dewit, ...> ;The Lancet. Gastroenterology & Hepatology. 2018 Oct 1
• 236 citations
  Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study.
  Dominique Baeten, Mikkel Østergaard, James Cheng-Chung Wei, Joachim Sieper, Pentti Järvinen, Lai-Shan Tam, Carlo Salvarani, Tae-Hwan Kim, Alan M. Solinger, Yakov Datse...> ;Annals of the Rheumatic Diseases. 2018 Jun 26
• 302 citations
  Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-con...
  Brian G. Feagan, William J. Sandborn, Geert R. D'Haens, Julián Panés, Arthur Kaser, Marc Ferrante, Edouard Louis, Denis Franchimont, Olivier Dewit, Ursula Seidler, Kyu...> ;Lancet. 2017 Apr 29
• 184 citations
  Anti–IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized,...
  James G. Krueger, Laura K. Ferris, Alan Menter, Frank Wagner, Alexander White, Sudha Visvanathan, Bojan Lalovic, Stella Aslanyan, Elaine E.L. Wang, David B. Hall, Alan...> ;The Journal of Allergy and Clinical Immunology. 2015 Jul 1
• 7 citations
  Short-course Combivir after single-dose nevirapine reduces but does not eliminate the emergence of nevirapine resistance in women.
  Sarah Palmer, Valerie F. Boltz, Jeremy Y. Chow, Neil A. Martinson, James McIntyre, Glenda Gray, Mark J. Hopley, Douglas L. Mayers, Patrick A. Robinson, David B. Hall, ...> ;Antiviral Therapy. 2011 Jan 1
• 17 citations
  Improving the prediction of virological response to tipranavir: the development and validation of a tipranavir-weighted mutation score.
  Jonathan M. Schapiro, Joseph Scherer, Charles A. Boucher, John D. Baxter, Clemens Tilke, Carlo Federico Perno, Franco Maggiolo, Maria Mercedes Santoro, David B. Hall> ;Antiviral Therapy. 2010 Oct 1
• 70 citations
  Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial.
  James McIntyre, Mark J. Hopley, Daya Moodley, Marie Eklund, Glenda E. Gray, David B. Hall, Patrick A. Robinson, Douglas L. Mayers, Neil A. Martinson> ;Plos Medicine. 2009 Oct 27
• 70 citations
  Recommendations for safety planning, data collection, evaluation and reporting during drug, biologic and vaccine development: a report of the safety planning, evaluati...
  Brenda J. Crowe, H. Amy Xia, Jesse A. Berlin, Douglas J. Watson, Hongliang Shi, Stephen L Lin, Juergen Kuebler, Robert C Schriver, Nancy C. Santanello, George Rocheste...> ;Clinical Trials. 2009 Oct 21
• 16 citations
  Case-Control Exploration of Relationships Between Early Rash or Liver Toxicity and Plasma Concentrations of Nevirapine and Primary Metabolites
  David B. Hall, Thomas R. MacGregor> ;HIV Clinical Trials. 2007 Nov 1
• 2 citations
  Relative antiviral efficacy should not be inferred from cross-trial comparisons.
  David B. Hall> ;HIV Medicine. 2007 Nov 1
• 13 citations
  Plasma lipid concentrations after 1.5 years of exposure to nevirapine or efavirenz together with stavudine and lamivudine.
  F. Van Leth, David B. Hall, J. M. A. Lange, Peter Reiss> ;HIV Medicine. 2006 Sep 1
• 11 citations
  A group sequential adaptive treatment assignment design for proof of concept and dose selection in headache trials.
  David B. Hall, Ulrich Meier, Hans-Cristoph Diener> ;Contemporary Clinical Trials. 2005 Jun 1
• 193 citations
  Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1.
  Frank van Leth, Prahpan Phanuphak, Erik S.G. Stroes, Brian Gazzard, Pedro Cahn, François Raffi, Robin Wood, Mark Bloch, Christine Katlama, John J.P. Kastelein, Mauro S...> ;Plos Medicine. 2004 Oct 19
• 245 citations
  A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child tr...
  Dhayendre Moodley, Jagidesa Moodley, Hoosen M. Coovadia, Glenda E. Gray, James McIntyre, Justus Hofmyer, Cheryl Nikodem, David B. Hall, Maria Gigliotti, Patrick A. Rob...> ;The Journal of Infectious Diseases. 2003 Mar 1
• 101 citations
  Antiviral effect and pharmacokinetic interaction between nevirapine and indinavir in persons infected with human immunodeficiency virus type 1.
  Robert L. Murphy, Jean Pierre Sommadossi, Michael Lamson, David B. Hall, Maureen Myers, Alex Dusek> ;The Journal of Infectious Diseases. 1999 May 1
• 53 citations
  Risk Factors for Crimean-Congo Hemorrhagic Fever in Rural Northern Senegal
  Louisa E. Chapman, Mark L. Wilson, David B. Hall, Bernard LeGuenno, Elizabeth A. Dykstra, Khalilou Ba, Susan P. Fisher-Hoch> ;The Journal of Infectious Diseases. 1991 Oct 1
• 18 citations
  Comparison of enzyme immunoassay with radioimmunoassay for the detection of antibody to hepatitis B core antigen as the only marker of hepatitis B infection in a popul...
  Alan J. Parkinson, Brian J. McMahon, David B. Hall, Donald Ritter, Mary Anne Fitzgerald> ;Journal of Medical Virology. 1990 Apr 1
• 54 citations
  PREVALENCE OF HEPATITIS B IN SELECTED ALASKAN ESKIMO VILLAGES
  Marshall T. Schreeder, Thomas R. Bender, Brian J. McMahon, Michael R. Moser, Bert L. Murphy, M. J. Sheller, William L. Heyward, David B. Hall, James E. Maynard> ;American Journal of Epidemiology. 1983 Oct 1
• Join now to see all